China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Chinese researchers develop advanced flexible material for wearable power generation
- Ten photos from across China: Feb 27 - March 5
- Manas in Xinjiang steps up improvement of sheep breeding
- Chinese scientists enable more realistic digital humans by building high-precision 3D facial database
- China to enhance childbirth support
- China's top legislature reviews draft law on national development planning
